Work

Applying early discovery safety science to eliminate chemical toxicity and improve the pre-clinical efficacy of focal adhesion kinase inhibitors

Year: 2015

Type: article

Source: Toxicology Letters

DOI: 10.1016/j.toxlet.2015.08.803

Authors: M. Anderton, S. Ashton, B. Barlaam, C. Jones, C. Jones

Institution: AstraZeneca (United Kingdom)

Language: English

Topic: Lysosomal Storage Disorders Research

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2592048897

FWCI:

Cites:

Cited by:

Related to: 10